1. Home
  2. EDU vs RGEN Comparison

EDU vs RGEN Comparison

Compare EDU & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDU
  • RGEN
  • Stock Information
  • Founded
  • EDU 1993
  • RGEN 1981
  • Country
  • EDU China
  • RGEN United States
  • Employees
  • EDU N/A
  • RGEN N/A
  • Industry
  • EDU Other Consumer Services
  • RGEN Medical/Dental Instruments
  • Sector
  • EDU Real Estate
  • RGEN Health Care
  • Exchange
  • EDU Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • EDU 7.3B
  • RGEN 8.0B
  • IPO Year
  • EDU 2006
  • RGEN N/A
  • Fundamental
  • Price
  • EDU $49.43
  • RGEN $133.72
  • Analyst Decision
  • EDU Hold
  • RGEN Buy
  • Analyst Count
  • EDU 4
  • RGEN 12
  • Target Price
  • EDU $48.50
  • RGEN $172.67
  • AVG Volume (30 Days)
  • EDU 1.3M
  • RGEN 863.9K
  • Earning Date
  • EDU 04-23-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • EDU 1.17%
  • RGEN N/A
  • EPS Growth
  • EDU 27.46
  • RGEN N/A
  • EPS
  • EDU 2.29
  • RGEN N/A
  • Revenue
  • EDU $4,793,786,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • EDU $16.08
  • RGEN $13.93
  • Revenue Next Year
  • EDU $15.80
  • RGEN $14.35
  • P/E Ratio
  • EDU $20.64
  • RGEN N/A
  • Revenue Growth
  • EDU 18.73
  • RGEN 4.88
  • 52 Week Low
  • EDU $40.66
  • RGEN $102.97
  • 52 Week High
  • EDU $89.33
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • EDU 58.49
  • RGEN 49.67
  • Support Level
  • EDU $46.06
  • RGEN $123.10
  • Resistance Level
  • EDU $50.40
  • RGEN $143.56
  • Average True Range (ATR)
  • EDU 1.46
  • RGEN 7.12
  • MACD
  • EDU 0.23
  • RGEN -0.81
  • Stochastic Oscillator
  • EDU 86.73
  • RGEN 41.10

About EDU New Oriental Education & Technology Group Inc.

New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: